Adverse Drug Reactions
Scientists at Korea University publish new data on adverse drug reactions
Published in Fitness and Wellness Business Week, January 31st, 2007
Research findings, "Pharmacokinetic and pharmacodynamic characteristics of a new S-amlodipine formulation in healthy Korean male subjects: a randomized, open-label, two-period, comparative, crossover study," are discussed in a new report. "Amlodipine, a dihydropyridine calcium channel antagonist, is prescribed for the management of angina and hypertension. It is used therapeutically as a racemic mixture, composed of S-and R-enantiomers, but its calcium channel-blocking effect is confined to S-amlodipine; R-amlodipine has 1000-fold less activity than its S-enantiomer," scientists writing in the journal Clinical Therapeutics report.
"The objective of this study was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness and Wellness Business Week
More Articles from Fitness and Wellness Business Week
- Adverse Drug Reactions
Scientists at AstraZeneca detail research in adverse drug reactions in children - Alcoholism Prevention
Researchers from Imperial College London, Imperial College report on findings in alcoholism prevention - Alcoholism Therapy
Research in the area of alcoholism therapy reported from Second Military Medical University, Department of Gastroenterology - Alzheimer Disease
Reports on alzheimer disease findings from Leiden Institute of Chemistry provide new insights - Analytical Chemistry
Research on analytical chemistry described by scientists at University of California, Department of Chemistry - Anesthesiology
Researchers from Toho University, Department of Anesthesiology detail new studies and findings in the area of anesthesiology - More from this issue of Fitness and Wellness Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
